The Effect of Cyp2d6 Gene Polymorphism on the Efficacy and Safety of Mirtazapine in Patients with Depressive Disorders Comorbid with Alcohol

Autor: Sergey S. Koporov, E. A. Bryun, Mikhail Sergeevich Zastrozhin, Alexander S. Sorokin, Elena A. Grishina, Kristina A Ryzhikova, Valery V. Smirnov, Dmitry A. Sychev, Valery V. Shipitsyn, Ludmila M. Savchenko, Oleg Z. Buzik

Publikováno v: Annals of the Russian academy of medical sciences. 74:185-191

Background: Alcohol dependence is often combined with affective disorders, in particular, depressive disorder, which adversely affects the prognosis of the course of both diseases. For the treatment of a depressive disorder, drugs from the group of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::201f8d55f520634ce0d554b5170676e2
https://doi.org/10.15690/vramn1075

Effect of Genetic Polymorphism of the CYP2D6 Gene on the Efficacy and Safety of Fluvoxamine in Major Depressive Disorder.

Autor: Zastrozhin M; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia.; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Skryabin V; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Smirnov V; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia; and.; NRC Institute of Immunology FMBA of Russia, Moscow, Russia., Zastrozhina A; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Grishina E; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Ryzhikova K; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Bure I; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Golovinskii P; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Koporov S; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Bryun E; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia.; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Sychev D; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.

Publikováno v: American journal of therapeutics [Am J Ther] 2021 Jun 03; Vol. 29 (1), pp. e26-e33. Date of Electronic Publication: 2021 Jun 03.